190 related articles for article (PubMed ID: 15198894)
21. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
Krebsbach PH; Zhang K; Malik AK; Kurachi K
J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
[TBL] [Abstract][Full Text] [Related]
23. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
24. Effects of recombinant retroviral vector mediated human insulin like growth factor-1 gene transfection on skeletal muscle growth in rat.
Rong SL; Lu YX; Liao YH; Wang XL; Guo HP; Chang C; Gao YZ; Mi SH; Wan JP
Chin Med J (Engl); 2006 Dec; 119(23):1991-8. PubMed ID: 17199944
[TBL] [Abstract][Full Text] [Related]
25. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
Konetschny C; Holzer GW; Falkner FG
J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
[TBL] [Abstract][Full Text] [Related]
26. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.
Nalbantoglu J; Larochelle N; Wolf E; Karpati G; Lochmuller H; Holland PC
J Virol; 2001 May; 75(9):4276-82. PubMed ID: 11287577
[TBL] [Abstract][Full Text] [Related]
27. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
28. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
Ohnishi N; Itoh K; Itoh Y; Baum C; Higashitsuji H; Yamaguchi K; Tsuji T; Okanoue T; Fujita J
Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis enhances factor IX delivery and persistence from retrievable human bioengineered muscle implants.
Thorrez L; Vandenburgh H; Callewaert N; Mertens N; Shansky J; Wang L; Arnout J; Collen D; Chuah M; Vandendriessche T
Mol Ther; 2006 Sep; 14(3):442-51. PubMed ID: 16750937
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
31. Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity.
Richardson TB; Kaspers J; Porter CD
Gene Ther; 2004 May; 11(9):775-83. PubMed ID: 14999228
[TBL] [Abstract][Full Text] [Related]
32. Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.
Fassati A; Bardoni A; Sironi M; Wells DJ; Bresolin N; Scarlato G; Hatanaka M; Yamaoka S; Dickson G
Hum Gene Ther; 1998 Nov; 9(17):2459-68. PubMed ID: 9853513
[TBL] [Abstract][Full Text] [Related]
33. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.
Hlavaty J; Portsmouth D; Stracke A; Salmons B; Günzburg WH; Renner M
Virology; 2004 Dec; 330(1):351-60. PubMed ID: 15527860
[TBL] [Abstract][Full Text] [Related]
34. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
Unsinger J; Kröger A; Hauser H; Wirth D
Mol Ther; 2001 Nov; 4(5):484-9. PubMed ID: 11708885
[TBL] [Abstract][Full Text] [Related]
35. Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo.
Kaptein LC; Breuer M; Valerio D; van Beusechem VW
Gene Ther; 1998 Mar; 5(3):320-30. PubMed ID: 9614551
[TBL] [Abstract][Full Text] [Related]
36. In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies.
Jiang A; Dornburg R
Gene Ther; 1999 Dec; 6(12):1982-7. PubMed ID: 10637449
[TBL] [Abstract][Full Text] [Related]
37. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
38. Formation and properties of hairpin and tetraplex structures of guanine-rich regulatory sequences of muscle-specific genes.
Yafe A; Etzioni S; Weisman-Shomer P; Fry M
Nucleic Acids Res; 2005; 33(9):2887-900. PubMed ID: 15908587
[TBL] [Abstract][Full Text] [Related]
39. Expression of biologically active human factor IX in human hematopoietic cells after retroviral vector-mediated gene transduction.
Hao QL; Malik P; Salazar R; Tang H; Gordon EM; Kohn DB
Hum Gene Ther; 1995 Jul; 6(7):873-80. PubMed ID: 7578406
[TBL] [Abstract][Full Text] [Related]
40. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
